Alexion Pharmaceuticals, Inc.,(Alexion) a biotechnology company, develops and delivers life-changing drug therapies for patients with serious and life-threatening medical conditions. It primarily engages in the discovery, development, and commercialization of biologic therapeutic products for the treatment of severe disease states, including hematologic diseases, cancer, and autoimmune disorders. The products include Pexelizumab, Eculizumab, Mab and DC-SIGN Mab. Through its subsidiaries, the Group is engaged in the discovery and development of a portfolio of additional antibody therapeutics targeting severe unmet medical needs. The company was founded in 1992.

Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of Alexion Pharmaceuticals. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's views on the company.

Scope

The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

A quick "one-stop-shop" to understand the company.
Enhance business/sales activities by understanding customers' businesses better.
Get detailed information and financial & strategic analysis on companies operating in your industry.
Identify prospective partners and suppliers - with key data on their businesses and locations.
Capitalize on competitors' weaknesses and target the market opportunities available to them.
Compare your company's financial trends with those of your peers / competitors.
Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Key Information
Key Ratios
Share Data
Performance Chart
List of Tables
List of Figures
- Key Facts
- Business Description
- Major Products and Services
- Overview
- History
- SWOT Analysis Overview
- Overview
- Alexion Pharmaceuticals - Strengths
- Lead Product Soliris
- Focused Research and Development Activities
- Alexion Pharmaceuticals - Weaknesses
- History of Operating Losses
- Legal Proceedings
- Alexion Pharmaceuticals - Opportunities
- License and Research and Development Agreements
- Focus on Oncology
- Emerging Markets
- Biotech Focus
- Alexion Pharmaceuticals - Threats
- Reimbursement Uncertainties
- Competition
- Tightening of FDA's Regulatory Oversight
- Key Competitors
- Key Employees
- Key Employee Biographies
- Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Financial Ratios
- Capital Market Ratios
- Annual Ratios
- Interim Ratios
- Ratio Charts
- Appendix
- Methodology
- Ratio Definitions
- About Global Markets Direct
- Contact Us
- Disclaimer
List of Tables
- Alexion Pharmaceuticals, Key Facts
- Alexion Pharmaceuticals, Key Ratios
- Alexion Pharmaceuticals, Share Data
- Alexion Pharmaceuticals, Key Facts
- Major Products and Services
- Alexion Pharmaceuticals, History
- Alexion Pharmaceuticals, Key Employees
- Alexion Pharmaceuticals, Key Employee Biographies
- Alexion Pharmaceuticals, Subsidiaries
- Alexion Pharmaceuticals, Ratios based on current share price
- Alexion Pharmaceuticals, Annual Ratios
- Alexion Pharmaceuticals, Interim Ratios
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
List of Figures
- Alexion Pharmaceuticals, Performance Chart (2004 - 2008)
- Alexion Pharmaceuticals, Ratio Charts

Pharmaceutical Market Research

Alexion Pharmaceuticals - Financial and Strategic Analysis Review